Study at a glance
How was vitamin A tested alongside active vitamin D?
Nine healthy adults each received four treatments on separate occasions: an inactive treatment, retinyl palmitate, calcitriol, and both together. The order was random and participants and researchers did not know which treatment was being given. Retinyl palmitate is a form of vitamin A. Calcitriol is active vitamin D, which differs from ordinary vitamin D3 supplements. Blood samples were collected the following day.
How did vitamin A change the blood calcium response?
Average adjusted blood calcium rose by 2.3% after calcitriol and 1.4% after the combination compared with the inactive treatment. Vitamin A alone lowered it by 1.0%. The combination’s rise was significantly smaller than the rise with calcitriol alone, but it was not eliminated. Adding vitamin A did not detectably change the fall in parathyroid hormone. No significant changes were found in the measured bone-breakdown or urinary-calcium markers.
Do the results explain why blood calcium changed?
No. Blood calcium is influenced by several processes. Intestinal absorption was proposed as an explanation but was not measured directly. Separate laboratory receptor experiments used a different vitamin A-related compound and did not prove the mechanism in these volunteers. A large observational study found no overall association between vitamin A intake and fractures after adjustment; a smaller-group finding remained uncertain and did not establish cause and effect.
Can these findings guide long-term vitamin supplement use?
This was a small, short experiment, not a study of long-term bone health or ordinary supplement use. It did not establish fracture effects, an ideal vitamin ratio, a dose threshold or a timing rule. The findings do not justify removing normal vitamin A foods, copying the research treatment or using vitamin A to counter suspected vitamin D toxicity.
Read the full article below ↓A small human experiment found that retinyl palmitate, a form of vitamin A, reduced the short-term blood-calcium rise caused by calcitriol. That finding is narrower than a claim that ordinary vitamin A intake blocks vitamin D₃ supplements or causes fractures. The distinction rests on the compounds administered, the measurements made and the time scale studied.
What was tested?
In Johansson and Melhus’s 2001 randomised, double-blind crossover, nine healthy adults completed four separate treatment occasions: placebo, retinyl palmitate, calcitriol, and their combination. A crossover means each participant experiences every treatment and supplies their own comparison. There were four men and five women, aged 24 to 41, with at least 14 days between occasions.
The tested doses were 15 mg retinyl palmitate and 2 µg calcitriol. Calcitriol is the active vitamin D hormone, 1,25-dihydroxyvitamin D₃. It is different from the cholecalciferol found in ordinary vitamin D₃ supplements, which must first undergo the stages described in Vitamin D Activation. The doses cannot be treated as interchangeable preparations.
Participants took the preparations at night. Five blood samples were collected the following day, around standardised meals. The investigators compared average post-dose measurements with each person’s placebo-day measurements. This was a short physiological experiment, not a long-term supplementation trial.
What changed?
Albumin-adjusted serum calcium rose by 2.3% with calcitriol and by 1.4% with the combination, relative to placebo. Retinyl palmitate alone produced a 1.0% decrease. The combination’s rise was significantly smaller than the rise with calcitriol alone, with p<0.05. It nevertheless remained a rise: vitamin A diminished this response rather than abolishing it.
Parathyroid hormone fell after calcitriol, but adding retinyl palmitate did not detectably change that response. No significant treatment effects were found for the measured bone-resorption marker or urinary calcium relative to creatinine. The result therefore concerns a particular calcium response, not demonstrated suppression of every effect of active vitamin D.
What was not measured?
Serum calcium is a concentration in blood, influenced by several organs and regulatory processes. It is not a direct measure of intestinal calcium absorption. The investigators proposed an intestinal explanation, but they did not use calcium tracers to measure absorption or trace calcium into the skeleton. Vitamin D and Calcium Physiology explains the broader system behind the blood measurement.
The trial also did not measure fracture risk, bone-density change or long-term outcomes. Nine participants can provide a useful within-person comparison, but cannot establish whether the finding applies equally to children, older adults, deficient populations or people with disease. No dose-response series established a threshold, optimal ratio or supplement timing rule.
How does the supporting evidence fit?
A receptor experiment by Thompson and colleagues showed that a retinoic acid ligand could modify vitamin D receptor-complex binding to DNA under controlled laboratory conditions. That supplies a possible molecular explanation, not proof that the same process caused the calcium change in the volunteers. Retinoic acid in that experiment and retinyl palmitate in the human trial were different exposures.
A large Women’s Health Initiative observational analysis found no overall association between vitamin A or retinol intake and hip or total fractures after full adjustment. A modest total-fracture association in the lower vitamin D-intake subgroup was more limited and depended on analysis choices. Estimated dietary intake was not a blood measurement, and the study did not randomise the nutrients.
Together, the studies show why a nutrient interaction needs a defined level of explanation. Molecular binding, serum chemistry and fractures are related questions, but evidence at one level cannot automatically establish the next. Vitamin D in Nutrient Networks places these relationships in the broader nutritional context.
What should the reader take from it?
The acute interaction is a legitimate finding worth understanding. Its clinical implications remain less certain. It does not justify removing normal sources of vitamin A, converting the research doses into a supplement combination, or using vitamin A to counter suspected vitamin D toxicity.
For the treatment comparisons, measurement limits, receptor evidence and fracture analysis, continue to Vitamin A and the Calcium Response to Calcitriol: Full Study.
Primary source and publication details
Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z. Vitamin A and retinol intakes and the risk of fractures among participants of the Women’s Health Initiative Observational Study. The American Journal of Clinical Nutrition. 2009;89:323 to 330. DOI: 10.3945/ajcn.2008.26451. PMID: 19056568.
Related reading
Bioconversion of vitamin D3 into calcitriol by Actinomyces hyovaginalis isolate CCASU: A11-2
Vitamin D3 is a fat-soluble prohormone that is activated inside the liver to produce 25-hydroxyvitamin D3 (calcidiol), and in the kidney to produce the fully active 1α, 25-dihydroxy vitamin D3 (calcitriol).
Original paper ↗Read more →Bioconversion of vitamin D3 to bioactive calcifediol and calcitriol as high-value compounds
Biological catalysis is an important approach for the production of high-value-added compounds, especially for products with complex structures.
Original paper ↗Read more →Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer
Vitamin D deficiency is a common problem worldwide.
Original paper ↗Read more →Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review
Photodynamic therapy (PDT) is a highly effective and widely adopted treatment strategy for many skin diseases, particularly for multiple actinic keratoses (AKs).
Original paper ↗Read more →Consumption of Yogurt in Canada and Its Contribution to Nutrient Intake and Diet Quality Among Canadians
Higher prevalence of yogurt consumption was noted among children aged 2 to 5 years old (47%) when compared to adults aged 19 to 54 years (18%).
Original paper ↗Read more →Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
The low proportion of gastric cancer (GC) patients with high HER2 expression limits the clinical application of trastuzumab, a humanized epidermal growth factor receptor 2 (HER2) antibody targeting for GC treatment.
Original paper ↗Read more →Dietary Calcium Intake and the Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis
Eight cross-sectional and two prospective cohort studies totaling 63,017 participants with 14,906 MetS cases were identified.
Original paper ↗Read more →Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer
The active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (calcitriol) has antiproliferative effects in non-aggressive prostate cancer, however, its effects in more aggressive model systems are still unclear.
Original paper ↗Read more →Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
The effects of parathyroid hormone and vitamin D supplementation on stroke in CAPD patients was evaluated.
Original paper ↗Read more →Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial
We aimed to investigate effects of vitamin D supplementation on IGF-1 (primary outcome) and calcitriol (1,25(OH)2D) concentrations (secondary outcome).
Original paper ↗Read more →Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature
Hypercalcemia is the most common oncologic metabolic emergency but very rarely observed in patients with gastrointestinal stromal tumour, which is a rare mesenchymal malignancy of the gastrointestinal tract.
Original paper ↗Read more →Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review
Risk of bias assessment was performed by two reviewers using Cochrane RoB‐2 for randomized controlled trials and JBI Critical Appraisal Tools for case reports, case series, and quasi‐experimental studies.
Original paper ↗Read more →Management of hypocalcemia following thyroid surgery in children
Pediatric post-thyroidectomy hypocalcemia management varies significantly from hospital to hospital.
Original paper ↗Read more →Menstrual Blood as a Non-Invasive Alternative for Monitoring Vitamin Levels
In this study, we aimed to assess the potential of using menstrual blood for determining vitamin levels by comparing their levels in menstrual blood to those in matched capillary blood samples.
Original paper ↗Read more →Peroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
Calcitriol is an active analog of vitamin D3 and has excellent physiological activities in regulating healthy immune function.
Original paper ↗Read more →Rapid Nontranscriptional Effects of Calcifediol and Calcitriol
The purpose of this paper is to provide an overview of the rapid, non-genomic effects of calcifediol and calcitriol, whose elucidation could improve the understanding of the vitamin D3 endocrine system.
Original paper ↗Read more →Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study
To further investigate secondary prevention of T1D with calcitriol and its less calcemic analog, paricalcitol, we initiated a prospective interventional non-randomized clinical trial, the PRECAL study (ISRCTN17354692).
Original paper ↗Read more →Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study
This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without diabetes.
Original paper ↗Read more →Simultaneous Determination of Vitamins D3 (Calcitriol, Cholecalciferol) and K2 (Menaquinone-4 and Menaquinone-7) in Dietary Supplements by UHPLC
The content and composition of dietary supplements is of great interest due to their increasing consumption and variety of available brand offered in the market.
Original paper ↗Read more →The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model
Viability, podocyte-related slit diaphragm proteins, morphology, function as a barrier was evaluated using flow cytometry, RT-PCR, confocal microscopy, and TEER analysis.
Original paper ↗Read more →Vitamin D levels and parathyroid hormone variations of children living in a subtropical climate: a data mining study
The aim of this study was to evaluate the seasonal 25-OHD levels and its associations with intact parathyroid hormone (iPTH) in Turkish children at all pediatric ages; and then to define a critical decision threshold level for 25-OHD deficiency in Turkish children.
Original paper ↗Read more →Original sources
Vitamin A Antagonizes Calcium Response to Vitamin D in Man
Published in Journal of Bone and Mineral Research (2001).
Publication details
Johansson S, Melhus H. Vitamin A Antagonizes Calcium Response to Vitamin D in Man. Journal of Bone and Mineral Research. 2001;16:1899 to 1905. DOI: 10.1359/jbmr.2001.16.10.1899. PMID: 11585356.
Heterodimeric DNA Binding by the Vitamin D Receptor and Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by 9-cis-Retinoic Acid: Evidence for Allosteric Receptor Interactions
Published in Journal of Biological Chemistry (1998).
Publication details
Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. Heterodimeric DNA Binding by the Vitamin D Receptor and Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by 9-cis-Retinoic Acid: Evidence for Allosteric Receptor Interactions. Journal of Biological Chemistry. 1998;273:8483 to 8491. DOI: 10.1074/jbc.273.14.8483. PMID: 9525962.